Executive Director Disease Area Strategy Team Lead

Disease Area Strategy Team (DAST) is a highly matrixed cross-functional and cross-regional team including R&D, commercial and Medical Affairs functions. The two DAST teams are tasked to monitor changes and trends in the therapeutic landscape of Breast Cancer or Lung Cancer and provide end-to-end strategic leadership and disease area expertise across the ADCs portfolio plus emerging multiple assets.

The Global Oncology Medical Affairs (GOMA) Disease Area Strategy Lead will be a core member of the DAST and will work collaboratively to provide strategic input and medical leadership to the cross-functional team. The GOMA Disease Area Strategy Lead is a critical senior position, accountable for providing strategic direction and matrix leadership to define the cross-asset Breast or Lung cancer medical plan. The GOMA DAST Lead will be responsible for the alignment, coordination and implementation of overall disease strategic medical initiatives that sit above individual assets. The GOMA DAST Lead will be accountable for working closely with the asset teams to establish and lead the overall Evidence Generation strategy for Breast or Lung cancer.

**Key responsibilities**:

- Incorporate GOMA perspective into broader disease area strategies developed by the DAST with a goal to provide guidance and prioritization to asset teams about opportunities and areas of unmet medical need and generate strategically aligned development strategies
- Lead the development of above-asset medical strategies for Breast or Lung cancer
- Collaborate with asset teams and cross-functional partners to deliver the above asset scientific narrative for Breast or Lung cancer
- Work in partnership with GMAT Leads to ensure that the DAST strategic expertise and input is aligned and integrated into the asset-level strategies and Medical Plans
- Work with Patient Advocacy Leads to incorporate the patient voice into the DAST Strategy
- Contribute to input-seeking activities (Field Medical Affairs Insights, competitive intelligence, advisory boards, etc.) and act on appropriate insights
- Lead cross-asset advisory board planning and execution
- Lead the overall evidence generation strategy for breast or lung cancer

**Personal skills and professional experience**:

- Minimum of 10 years of pharmaceutical industry experience
- Experience with oncology medical strategies is required
- Knowledge of oncology basic science, mechanisms of action, biomarkers, clinical treatment landscapes in breast or lung cancer is essential
- Strong background in evidence generation required, with previous study leadership in clinical development or medical affairs
- Launch experience is required
- Ability to travel up to 25% domestic and/or international travel

**Competencies**:

- Proven track record as a leader of a highly matrixed team with strong interpersonal skills to influence cross-functional and
- cross-regional senior leaders with collaborative mindset (R&D, Commercial, and beyond) required
- Demonstrated success as a project leader in planning and executing strategies for global drug development, commercialization, and life cycle management
- Has a strong expert network and can consult key external disease experts (KEE) on disease area strategy, as needed preferred

**What we offer**:
**Working at Daiichi Sankyo**:
At Daiichi Sankyo in Europe, we offer a workplace where your voice is heard. Everything we do, we do with a high level of commitment and a clear focus on patients’ needs. We know that our bold ambition to change patients’ lives for the better can only be achieved through the power of collaboration and the exploration of new approaches. Thus, we encourage our colleagues across Europe to be courageous, to bring their ideas to the table and to embrace opportunities to grow. When you join our European family, you will be a part of a dynamic company where everyone, no matter their role, rolls up their sleeves and gets things done.